Novel 1550-nm Nonablative Resurfacing Laser With Focal Point Technology Improves Fine Lines and Wrinkles With High Energy Delivery
Listen to this summary
The authors aimed to evaluate the effectiveness and safety of a novel 1550-nm nonablative resurfacing laser utilizing Focal Point Technology for improving fine lines and wrinkles across various Fitzpatrick skin types. Their retrospective analysis of 33 subjects demonstrated significant improvement in wrinkle scores and high agreement among blinded reviewers in photographic assessments, indicating that this new laser technology is both safe and effective for treating skin aging.
This is one of 33,000+ journals available on OSLR. Try it free for 14 days.
Free 14-day trial. 33,000+ journals. Cancel anytime.
More from Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]
View all →Jun 10, 2026 · Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]
Defining the Ideal Cranial Vault Height Ratio Via Morphometric Analysis: A Preliminary Study
Jun 3, 2026 · Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]
Lasers and Acquired Melanocytic Nevi: A Systematic Review
More in Dermatology
View all →Jun 24, 2026 · The New England journal of medicine
Prevention and Treatment of Peanut Allergy
Jun 24, 2026 · Lancet (London, England)
Efficacy and safety of tirofiban after successful endovascular reperfusion in acute ischaemic stroke (ATTRACTION) in China: a multicentre, double-blind, randomised controlled trial
Jun 24, 2026 · Lancet (London, England)
Safety, pharmacokinetics, and exploratory efficacy of the oral ghrelin receptor agonist AC01 in heart failure with reduced ejection fraction (GOAL-HF1): a randomised, double-blind, placebo-controlled, phase 1b/2a study
Jun 24, 2026 · The New England journal of medicine
A Pragmatic Trial of a 6-Month Strategy for Rifampicin-Resistant Tuberculosis
Jun 24, 2026 · The New England journal of medicine
Ten-Year Outcomes after CAR T-Cell Therapy for B-Cell Lymphomas
Jun 23, 2026 · Lancet (London, England)
Non-invasive removal of the Smart tracheal occlusion device for fetal congenital diaphragmatic hernia: a single-arm, open-label, phase 1 study
"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."
Dr. Jennifer Thompson
Portland, OR
Stay current without falling behind
33,000+ journals. 3-minute audio summaries. Free for 14 days.
